Evoke Pharmaadmin2022-01-15T17:24:47+00:00 Project Description Follow-On Offering Common Stock . $14,375,000 Sole Book-Runner January 2021 Related Project Details Categories: confidentially-marketed Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail Related Projects